| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Martin Reivich, Jay D Amsterdam, David J Brunswick, Chyng Yann Shiu. PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression. Journal of affective disorders. vol 82. issue 2. 2005-02-23. PMID:15488265. |
alterations in the brain serotonin (5-ht) system have been found in patients with depression. |
2005-02-23 |
2023-08-12 |
Not clear |
| Stuart J Warden, Alexander G Robling, Megan S Sanders, Michael M Bliziotes, Charles H Turne. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology. vol 146. issue 2. 2005-02-17. PMID:15539550. |
selective serotonin-reuptake inhibitors (ssris) antagonize the serotonin (5-hydroxytryptamine) transporter (5-htt), and are frequently prescribed to children and adolescents to treat depression. |
2005-02-17 |
2023-08-12 |
mouse |
| J M Loftis, J M Wall, E Linardatos, S Benvenga, P Hause. A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C. Journal of endocrinological investigation. vol 27. issue 7. 2005-02-15. PMID:15505982. |
patients who developed ifn-induced depression were treated with selective serotonin reuptake inhibitor antidepressants. |
2005-02-15 |
2023-08-12 |
Not clear |
| Yvette I Sheline, Mark A Mintun, Deanna M Barch, Consuelo Wilkins, Abraham Z Snyder, Stephen M Moerlei. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 29. issue 12. 2005-02-14. PMID:15367923. |
we used positron emission tomography (pet) and [18f]altanserin, a ligand with high affinity for the 5-ht(2a) receptor, to examine the relationship between 5-ht(2a) receptor density and depression. |
2005-02-14 |
2023-08-12 |
human |
| Yvette I Sheline, Mark A Mintun, Deanna M Barch, Consuelo Wilkins, Abraham Z Snyder, Stephen M Moerlei. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 29. issue 12. 2005-02-14. PMID:15367923. |
depressed subjects not previously treated for depression (n = 6) had less hippocampal 5-ht(2a) receptor binding (p = 0.04) than previously treated subjects (n = 10). |
2005-02-14 |
2023-08-12 |
human |
| Carolyn Cidis Meltzer, Julie C Price, Chester A Mathis, Meryl A Butters, Scott K Ziolko, Eydie Moses-Kolko, Sati Mazumdar, Benoit H Mulsant, Patricia R Houck, Brian J Lopresti, Lisa A Weissfeld, Charles F Reynold. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 29. issue 12. 2005-02-14. PMID:15483563. |
serotonin 1a receptor binding and treatment response in late-life depression. |
2005-02-14 |
2023-08-12 |
human |
| Carolyn Cidis Meltzer, Julie C Price, Chester A Mathis, Meryl A Butters, Scott K Ziolko, Eydie Moses-Kolko, Sati Mazumdar, Benoit H Mulsant, Patricia R Houck, Brian J Lopresti, Lisa A Weissfeld, Charles F Reynold. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 29. issue 12. 2005-02-14. PMID:15483563. |
our finding of decreased [11c]way 100635 binding in the brainstem region of the drn in elderly depressed patients supports evidence of altered 5-ht(1a) autoreceptor function in depression. |
2005-02-14 |
2023-08-12 |
human |
| Carolyn Cidis Meltzer, Julie C Price, Chester A Mathis, Meryl A Butters, Scott K Ziolko, Eydie Moses-Kolko, Sati Mazumdar, Benoit H Mulsant, Patricia R Houck, Brian J Lopresti, Lisa A Weissfeld, Charles F Reynold. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 29. issue 12. 2005-02-14. PMID:15483563. |
further, this work indicates that dysfunction in autoreceptor activity may play a central role in the mechanisms underlying treatment response to selective serotonin reuptake inhibitors in late-life depression. |
2005-02-14 |
2023-08-12 |
human |
| E Pretoriu. Asthma medication may influence the psychological functioning of children. Medical hypotheses. vol 63. issue 3. 2005-02-10. PMID:15288358. |
therefore, the hypothesis suggest that some children using asthma medication that lowers serotonin levels, might present with symptoms of depression adhd, oppositional defiant disorder and even conduct disorder. |
2005-02-10 |
2023-08-12 |
Not clear |
| Ellen M Whyte, James Basinski, Panthea Farhi, Mary Amanda Dew, Amy Begley, Benoit H Mulsant, Charles F Reynold. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. The Journal of clinical psychiatry. vol 65. issue 12. 2005-02-07. PMID:15641868. |
geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. |
2005-02-07 |
2023-08-12 |
human |
| Rajamannar Ramasubb. Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review. The Journal of clinical psychiatry. vol 65. issue 12. 2005-02-07. PMID:15641869. |
an understanding of cerebro-vascular effects of selective serotonin reuptake inhibitors (ssris) is essential, since ssris are a widely used antidepressant, serotonin is a vasoactive and thrombostatic amine, and there is a bidirectional relationship between depression and cerebrovascular disease. |
2005-02-07 |
2023-08-12 |
Not clear |
| Joan Kaufman, Bao-Zhu Yang, Heather Douglas-Palumberi, Shadi Houshyar, Deborah Lipschitz, John H Krystal, Joel Gelernte. Social supports and serotonin transporter gene moderate depression in maltreated children. Proceedings of the National Academy of Sciences of the United States of America. vol 101. issue 49. 2005-02-04. PMID:15563601. |
social supports and serotonin transporter gene moderate depression in maltreated children. |
2005-02-04 |
2023-08-12 |
Not clear |
| Joan Kaufman, Bao-Zhu Yang, Heather Douglas-Palumberi, Shadi Houshyar, Deborah Lipschitz, John H Krystal, Joel Gelernte. Social supports and serotonin transporter gene moderate depression in maltreated children. Proceedings of the National Academy of Sciences of the United States of America. vol 101. issue 49. 2005-02-04. PMID:15563601. |
in this study, measures of the quality and availability of social supports were found to moderate risk for depression associated with a history of maltreatment and the presence of the short (s) allele of the serotonin transporter gene promoter polymorphism (5-httlpr). |
2005-02-04 |
2023-08-12 |
Not clear |
| Fenghua Chen, Mads Breum Larsen, Henrik Amtoft Neubauer, Connie Sánchez, Per Plenge, Ove Wibor. Characterization of an allosteric citalopram-binding site at the serotonin transporter. Journal of neurochemistry. vol 92. issue 1. 2005-02-02. PMID:15606893. |
the serotonin transporter (sert), which belongs to a family of sodium/chloride-dependent transporters, is the major pharmacological target in the treatment of several clinical disorders, including depression and anxiety. |
2005-02-02 |
2023-08-12 |
human |
| Nancy T Artinian, Charles G Artinian, Mitzi M Saunder. Identifying and treating depression in patients with heart failure. The Journal of cardiovascular nursing. vol 19. issue 6 Suppl. 2005-02-01. PMID:15529074. |
categories of antidepressant drugs, including serotonin reuptake inhibitors, tricyclic antidepressants, and miscellaneous antidepressants, are reviewed relative to treating depression in patients with hf. |
2005-02-01 |
2023-08-12 |
Not clear |
| J M Fegert, B Herpertz-Dahlman. [Administration of selective serotonin reuptake inhibitors (SSRI) for depression in children and adolescents]. Der Nervenarzt. vol 75. issue 9. 2005-01-28. PMID:15316621. |
[administration of selective serotonin reuptake inhibitors (ssri) for depression in children and adolescents]. |
2005-01-28 |
2023-08-12 |
Not clear |
| D Jeffrey Newport, Michael J Owens, David L Knight, Kim Ragan, Neal Morgan, Charles B Nemeroff, Zachary N Stow. Alterations in platelet serotonin transporter binding in women with postpartum onset major depression. Journal of psychiatric research. vol 38. issue 5. 2005-01-24. PMID:15380396. |
alterations in platelet serotonin transporter binding in women with postpartum onset major depression. |
2005-01-24 |
2023-08-12 |
human |
| Eberhard Fuchs, Boldizsár Czéh, Maarten H P Kole, Thomas Michaelis, Paul J Lucasse. Alterations of neuroplasticity in depression: the hippocampus and beyond. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 14 Suppl 5. 2005-01-19. PMID:15550346. |
early hypotheses on the pathophysiology of major depression were based on aberrant intrasynaptic concentrations of mainly the neurotransmitters serotonin and norepinephrine. |
2005-01-19 |
2023-08-12 |
Not clear |
| Ian C K Wong, Frank M C Besag, Paramala J Santosh, Macey L Murra. Use of selective serotonin reuptake inhibitors in children and adolescents. Drug safety. vol 27. issue 13. 2005-01-18. PMID:15471506. |
depression is a serious condition, associated with considerable morbidity and mortality; selective serotonin reuptake inhibitors (ssris) were commonly used in its treatment in child and adolescent psychiatry until recently. |
2005-01-18 |
2023-08-12 |
Not clear |
| Jim Mille. Managing antidepression overdoses. Emergency medical services. vol 33. issue 10. 2005-01-18. PMID:15553532. |
depression is a physiological disorder that is medically treated by increasing the bodily amount of one or all of the following neurotransmitters: serotonin, dopamine and norepinephrine. |
2005-01-18 |
2023-08-12 |
Not clear |